Six-membered heterocycles useful as serine protease inhibitors

Details for Australian Patent Application No. 2006325746 (hide)

Owner Bristol-Myers Squibb Company

Inventors Corte, James R.

Agent A J Park

Pub. Number AU-A-2006325746

PCT Pub. Number WO2007/070818

Priority 60/750,416 14.12.05 US

Filing date 13 December 2006

Wipo publication date 21 June 2007

International Classifications

C07D 213/54 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/444 (2006.01)

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

C07D 213/64 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/89 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 239/26 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

12 June 2008 PCT application entered the National Phase

  PCT publication WO2007/070818 Priority application(s): WO2007/070818

6 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006325752-Use of eLF-5A to kill multiple myeloma cells

2006325738-Non-sulfided Ni-based hydrocracking catalysts